<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Mol Genet Genomic Med</journal-id>
<journal-id journal-id-type="iso-abbrev">Mol Genet Genomic Med</journal-id>
<journal-id journal-id-type="doi">10.1002/(ISSN)2324-9269</journal-id>
<journal-id journal-id-type="publisher-id">MGG3</journal-id>
<journal-title-group>
<journal-title>Molecular Genetics &amp; Genomic Medicine</journal-title>
</journal-title-group>
<issn pub-type="epub">2324-9269</issn>
<publisher>
<publisher-name>John Wiley and Sons Inc.</publisher-name>
<publisher-loc>Hoboken</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">32277595</article-id>
<article-id pub-id-type="pmc">7284027</article-id>
<article-id pub-id-type="doi">10.1002/mgg3.1086</article-id>
<article-id pub-id-type="publisher-id">MGG31086</article-id>
<article-categories>
<subj-group subj-group-type="overline">
<subject>Original Article</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Original Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Haploinsufficiency of the <italic>FOXA2</italic> associated with a complex clinical phenotype</article-title>
<alt-title alt-title-type="left-running-head">MOHAMMED et al.</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" id="mgg31086-cr-0001">
<name>
<surname>Mohammed</surname>
<given-names>Idris</given-names>
</name>
<xref ref-type="aff" rid="mgg31086-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="mgg31086-aff-0002">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="mgg31086-cr-0002">
<name>
<surname>Al‐Khawaga</surname>
<given-names>Sara</given-names>
</name>
<contrib-id authenticated="false" contrib-id-type="orcid">https://orcid.org/0000-0002-3010-309X</contrib-id>
<xref ref-type="aff" rid="mgg31086-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="mgg31086-aff-0002">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="mgg31086-cr-0003">
<name>
<surname>Bohanna</surname>
<given-names>David</given-names>
</name>
<xref ref-type="aff" rid="mgg31086-aff-0003">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="mgg31086-cr-0004">
<name>
<surname>Shabani</surname>
<given-names>Abdusamea</given-names>
</name>
<xref ref-type="aff" rid="mgg31086-aff-0004">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="mgg31086-cr-0005">
<name>
<surname>Khan</surname>
<given-names>Faiyaz</given-names>
</name>
<xref ref-type="aff" rid="mgg31086-aff-0002">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="mgg31086-cr-0006">
<name>
<surname>Love</surname>
<given-names>Donald R.</given-names>
</name>
<xref ref-type="aff" rid="mgg31086-aff-0003">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="mgg31086-cr-0007">
<name>
<surname>Nawaz</surname>
<given-names>Zafar</given-names>
</name>
<xref ref-type="aff" rid="mgg31086-aff-0005">
<sup>5</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes" id="mgg31086-cr-0008">
<name>
<surname>Hussain</surname>
<given-names>Khalid</given-names>
</name>
<contrib-id authenticated="false" contrib-id-type="orcid">https://orcid.org/0000-0002-5480-7112</contrib-id>
<xref ref-type="aff" rid="mgg31086-aff-0002">
<sup>2</sup>
</xref>
<address>
<email>khussain@sidra.org</email>
</address>
</contrib>
</contrib-group>
<aff id="mgg31086-aff-0001">
<label><sup>1</sup></label>
<named-content content-type="organisation-division">College of Health &amp; Life Sciences</named-content>
<institution>Hamad Bin Khalifa University</institution>
<city>Doha</city>
<country country="QA">Qatar</country>
</aff>
<aff id="mgg31086-aff-0002">
<label><sup>2</sup></label>
<named-content content-type="organisation-division">Division of Endocrinology</named-content>
<named-content content-type="organisation-division">Department of Pediatric Medicine</named-content>
<institution>Sidra Medicine</institution>
<city>Doha</city>
<country country="QA">Qatar</country>
</aff>
<aff id="mgg31086-aff-0003">
<label><sup>3</sup></label>
<named-content content-type="organisation-division">Department of Radiology</named-content>
<institution>Sidra Medicine</institution>
<city>Doha</city>
<country country="QA">Qatar</country>
</aff>
<aff id="mgg31086-aff-0004">
<label><sup>4</sup></label>
<named-content content-type="organisation-division">Division of Pathology Genetics</named-content>
<named-content content-type="organisation-division">Department of Pathology</named-content>
<institution>Sidra Medicine</institution>
<city>Doha</city>
<country country="QA">Qatar</country>
</aff>
<aff id="mgg31086-aff-0005">
<label><sup>5</sup></label>
<named-content content-type="organisation-division">Diagnostic Genomic Division</named-content>
<named-content content-type="organisation-division">Department of Laboratory Medicine and Pathology</named-content>
<institution>Hamad Medical Corporation</institution>
<city>Doha</city>
<country country="QA">Qatar</country>
</aff>
<author-notes>
<corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold><break></break>
Khalid Hussain, Department of Pediatrics, Division of Endocrinology, Sidra Medicine, Al Luqta Street, Education City, North Campus, Doha, Qatar.<break></break>
Email: <email>khussain@sidra.org</email><break></break></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>11</day>
<month>4</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="collection">
<month>6</month>
<year>2020</year>
</pub-date>
<volume>8</volume>
<issue>6</issue>
<issue-id pub-id-type="doi">10.1002/mgg3.v8.6</issue-id>
<elocation-id>e1086</elocation-id>
<history>
<date date-type="received">
<day>16</day>
<month>9</month>
<year>2019</year>
</date>
<date date-type="rev-recd">
<day>06</day>
<month>11</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>14</day>
<month>11</month>
<year>2019</year>
</date>
</history>
<permissions>
<!--<copyright-statement content-type="issue-copyright"> Copyright &#x000a9; 2020 John Wiley & Sons Ltd. <copyright-statement>-->
<copyright-statement content-type="article-copyright">© 2019 The Authors. <italic>Molecular Genetics &amp; Genomic Medicine</italic> published by Wiley Periodicals, Inc.</copyright-statement>
<license license-type="creativeCommonsBy">
<license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="file:MGG3-8-e1086.pdf"></self-uri>
<abstract id="mgg31086-abs-0001">
<title>Abstract</title>
<sec id="mgg31086-sec-0001">
<title>Background</title>
<p>There are few reports describing the proximal deletions of the short arm of chromosome 20, making it difficult to predict the likely consequences of these deletions. Most previously reported cases have described the association of 20p11.2 deletions with Alagille syndrome, while there are others that include phenotypes such as panhypopituitarism, craniofacial dysmorphism, polysplenia, autism, and Hirschsprung disease.</p>
</sec>
<sec id="mgg31086-sec-0002">
<title>Methods</title>
<p>Molecular karyotyping, cytogenetics, and DNA sequencing were undertaken in a child to study the genetic basis of a complex phenotype consisting of craniofacial dysmorphism, ocular abnormalities, ectopic inguinal testes, polysplenia, growth hormone deficiency, central hypothyroidism, and gastrointestinal system anomalies.</p>
</sec>
<sec id="mgg31086-sec-0003">
<title>Results</title>
<p>We report the smallest described de novo proximal 20p11.2 deletion, which deletes only the <italic>FOXA2</italic> leading to the above complex phenotype.</p>
</sec>
<sec id="mgg31086-sec-0004">
<title>Conclusions</title>
<p>Haploinsufficiency of the <italic>FOXA2</italic> only gene is associated with a multisystem disorder.</p>
</sec>
</abstract>
<abstract abstract-type="graphical" id="mgg31086-abs-0002">
<p>Haploinsufficiency of the <italic>FOXA2</italic> leads to a complex phenotype consisting of craniofacial dysmorphism, ocular abnormalities, ectopic inguinal testes, polysplenia, growth hormone deficiency, central hypothyroidism, and gastrointestinal system anomalies.<boxed-text content-type="graphic" id="mgg31086-blkfxd-0001" orientation="portrait" position="anchor"><graphic id="nlm-graphic-1" orientation="portrait" position="anchor" xlink:href="MGG3-8-e1086-g006.jpg"></graphic></boxed-text>
</p>
</abstract>
<kwd-group kwd-group-type="author-generated">
<kwd id="mgg31086-kwd-0001">20p11.2 deletion</kwd>
<kwd id="mgg31086-kwd-0002">
<italic>FOXA2</italic>
</kwd>
<kwd id="mgg31086-kwd-0003">growth hormone deficiency</kwd>
<kwd id="mgg31086-kwd-0004">haploinsufficiency</kwd>
<kwd id="mgg31086-kwd-0005">hypothyroidism</kwd>
</kwd-group>
<funding-group>
<award-group id="funding-0001">
<funding-source>Qatar National Library</funding-source>
</award-group>
</funding-group>
<counts>
<fig-count count="5"></fig-count>
<table-count count="2"></table-count>
<page-count count="8"></page-count>
<word-count count="4403"></word-count>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>source-schema-version-number</meta-name>
<meta-value>2.0</meta-value>
</custom-meta>
<custom-meta>
<meta-name>cover-date</meta-name>
<meta-value>June 2020</meta-value>
</custom-meta>
<custom-meta>
<meta-name>details-of-publishers-convertor</meta-name>
<meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:5.8.4 mode:remove_FC converted:10.06.2020</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
<notes>
<p content-type="self-citation">
<mixed-citation id="mgg31086-cit-1001" publication-type="journal">
<string-name>
<surname>Mohammed</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Al‐Khawaga</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Bohanna</surname>
<given-names>D</given-names>
</string-name>, et al. <article-title>Haploinsufficiency of the <italic>FOXA2</italic> associated with a complex clinical phenotype</article-title>. <source xml:lang="en"/>Mol Genet Genomic Med. <year>2020</year>;<volume>8</volume>:<elocation-id>e1086</elocation-id>
<pub-id pub-id-type="doi">10.1002/mgg3.1086</pub-id>
</mixed-citation>
</p>
<fn-group id="mgg31086-ntgp-0001">
<fn fn-type="funding" id="mgg31086-note-0001">
<p>
<bold>Funding information</bold>
</p>
<p>The publication of this article was funded by the Qatar National Library.</p>
</fn>
</fn-group>
</notes>
</front>
<body id="mgg31086-body-0001">
<sec id="mgg31086-sec-0005">
<label>1</label>
<title>INTRODUCTION</title>
<p>The forkhead box A (FOXA) transcription factor plays an important role in multiple stages of life, from early development to endoderm formation, regulation of genes involved in growth and proliferation, fertility, organogenesis and differentiation, metabolism, homeostasis, and the immune system (Friedman &amp; Kaestner, <xref ref-type="ref" rid="mgg31086-bib-0007">2006</xref>; Kaestner, <xref ref-type="ref" rid="mgg31086-bib-0016">2010</xref>; Kelleher et al., <xref ref-type="ref" rid="mgg31086-bib-0019">2017</xref>). <italic>FOXA2</italic> expression occurs in the primitive streak and in the node of the embryo, which are both crucial for gastrulation. <italic>FOXA2</italic> expression is also active in the anterior axial mesoderm, definitive endoderm formation, as well as ectoderm‐derived neural tissues and endoderm‐derived tissues (pancreas, liver, thyroid, prostate, and lung) in early development and adulthood (Besnard, Wert, Hull, &amp; Whitsett, <xref ref-type="ref" rid="mgg31086-bib-0003">2004</xref>; Friedman &amp; Kaestner, <xref ref-type="ref" rid="mgg31086-bib-0007">2006</xref>; Kaestner, <xref ref-type="ref" rid="mgg31086-bib-0015">2000</xref>).</p>
<p>β‐cell‐specific <italic>FOXA2</italic>‐knockout mice exhibit severe hyperinsulinemic hypoglycemia and hypoglucagonemia phenotype due to an increased insulin to glucagon ratio (3–4 fold), and die shortly after birth due to inhibition of notochord and endoderm formation (Gao et al., <xref ref-type="ref" rid="mgg31086-bib-0008">2010</xref>; Lantz et al., <xref ref-type="ref" rid="mgg31086-bib-0020">2004</xref>; Sund et al., <xref ref-type="ref" rid="mgg31086-bib-0023">2001</xref>). The phenotypic outcome is likely due to the role that <italic>FOXA2</italic> plays in regulating the expression of genes in pancreatic β‐cells that are important in glucose sensing and insulin secretion, including <italic>KCNJ11</italic>, <italic>ABCC8</italic>, <italic>GLUT2</italic>, and <italic>GCK</italic> (Heddad Masson et al., <xref ref-type="ref" rid="mgg31086-bib-0014">2014</xref>; Wang, Gauthier, Hagenfeldt‐Johansson, Iezzi, &amp; Wollheim, <xref ref-type="ref" rid="mgg31086-bib-0026">2002</xref>).</p>
<p>There are very few reports describing the constitutional heterozygous proximal deletions of chromosome 20 short arm (20p), making it difficult to predict phenotypic outcomes. Two reports have described inherited 20p deletions from normal mosaic carrier mothers: the first manifesting panhypopituitarism, and craniofacial dysmorphism (Garcia‐Heras, Kilani, Martin, &amp; Lamp, <xref ref-type="ref" rid="mgg31086-bib-0010">2005</xref>); and the second, a patient manifesting inadequate bile ducts, heart defect, corneal abnormality, and mild developmental delay (Laufer‐Cahana et al., <xref ref-type="ref" rid="mgg31086-bib-0021">2002</xref>). Earlier studies have described patients with heterozygous 20p deletions with varying phenotypes including craniofacial dysmorphism, Hirschsprung disease, cognitive delay, autistic behavior, gastrointestinal anomalies, hypoglycemia, seizures, panhypopituitarism, endoderm‐derived organ abnormalities, and hearing loss (Dayem‐Quere et al., <xref ref-type="ref" rid="mgg31086-bib-0005">2013</xref>; Garcia‐Heras et al., <xref ref-type="ref" rid="mgg31086-bib-0010">2005</xref>; Kale, Patil, &amp; Pandit, <xref ref-type="ref" rid="mgg31086-bib-0017">2017</xref>; Kamath et al., <xref ref-type="ref" rid="mgg31086-bib-0018">2009</xref>; Michaelis et al., <xref ref-type="ref" rid="mgg31086-bib-0022">1997</xref>). Most reported chromosome 20p deletion cases constitute interstitial deletions involving the 20p12 region. This region encompasses the <italic>JAG1</italic>, mutations in which are associated with Alagille syndrome. Patients with Alagille syndrome show diverse phenotypes because of variable expressivity (Goldman &amp; Pranikoff, <xref ref-type="ref" rid="mgg31086-bib-0012">2011</xref>; Guegan, Stals, Day, Turnpenny, &amp; Ellard, <xref ref-type="ref" rid="mgg31086-bib-0013">2012</xref>).</p>
<p>Heterozygous deletion of the <italic>FOXA2</italic> results in mild phenotypes and moderately decreased glucagon gene expression and α‐cell differentiation (Gao et al., <xref ref-type="ref" rid="mgg31086-bib-0008">2010</xref>; Heddad Masson et al., <xref ref-type="ref" rid="mgg31086-bib-0014">2014</xref>). One copy of the <italic>FOXA2</italic> appears to be enough for the development of a normal pancreas with all mature cell types (Ang &amp; Rossant, <xref ref-type="ref" rid="mgg31086-bib-0002">1994</xref>; Gao et al., <xref ref-type="ref" rid="mgg31086-bib-0009">2008</xref>; Weinstein et al., <xref ref-type="ref" rid="mgg31086-bib-0027">1994</xref>). Recently, two studies reported an association of <italic>FOXA2</italic> heterozygous mutations with hyperinsulinism, hypoglycemia, pituitary hormone deficiency, craniofacial, and endoderm‐derived organ abnormalities (Giri et al., <xref ref-type="ref" rid="mgg31086-bib-0011">2017</xref>; Vajravelu et al., <xref ref-type="ref" rid="mgg31086-bib-0025">2018</xref>).</p>
<p>Here, we report a 10‐year‐old boy with dysmorphic features, growth hormone (GH) deficiency, and central hypothyroidism who carries a de novo t(6;20) chromosome translocation with a heterozygous proximal 20p11.2 deletion.</p>
</sec>
<sec id="mgg31086-sec-0006">
<label>2</label>
<title>CASE PRESENTATION</title>
<p>The patient is the first child of healthy non‐consanguineous couple (mother: 21 years, father: 31 years old), with no relevant family history. The patient was born at 29 weeks of gestation by cesarean section, with low birth weight of 900g. A subsequent sister was born at term and had a normal karyotype. He presented at the age of 6 years with short stature where his height and weight at 6 years of age were two standard deviation (−2 <italic>SD</italic>) below the mean with a delayed bone age (Figure <xref ref-type="fig" rid="mgg31086-fig-0001">1</xref>), and was noted previously to have multiple dysmorphic features. Investigations confirmed GH deficiency (Table <xref ref-type="table" rid="mgg31086-tbl-0001">1</xref>), central hypothyroidism, poor weight gain, repeated episodes of abdominal pain, vomiting, and diarrhea. The patient was commenced on replacement therapy with recombinant GH (0.025 mg/kg per day with excellent response in terms of growth velocity) and levothyroxine 50 mcg daily. The serum ACTH and cortisol levels were normal. Pelvic ultrasound showed ectopic inguinal testes with the left being smaller than right. Polysplenia (three spleens) were noted on ultrasound, the largest measuring 5.5 cm in length. A barium follow through showed evidence of partial malrotation (with the third part of the duodenum incompletely crossing the midline and jejunal loops located on the right side). Contrast swallow study showed major gastroesophageal reflux, low‐lying duodenojejunal flexure with the small bowel loops seen on the right side of the abdomen suggestive of malrotation. Brain MRI scan showed that the sella turcica was shallow and underdeveloped with minor sella‐associated tissue content. These findings indicate hypoplasia of the sella and associated sella tissue (predominantly anterior pituitary) components and infundibulum (at the connection between the hypothalamus and the posterior pituitary). The physiological posterior pituitary tissue components were ectopically positioned within the region of the tuber cinereum and the lateral ventricles were slightly capacious (Figure <xref ref-type="fig" rid="mgg31086-fig-0002">2</xref>). Continuous glucose patient monitoring for 7 days showed normal glucose levels, and diagnostic fast for 18 hr did not elicit any hypoglycemia. Other laboratory investigations, including serum glucagon level, kidney and liver function tests, were normal (Table <xref ref-type="table" rid="mgg31086-tbl-0001">1</xref>).</p>
<fig fig-type="Figure" id="mgg31086-fig-0001" orientation="portrait" position="float" xml:lang="en">
<label>Figure 1</label>
<caption>
<p>Growth chart illustration of growth abnormalities observed in the patient. Black dots, stature, and height before treatment. Red dots, stature, and height after treatment. The vertical red arrow indicates the age of commencement of growth hormone therapy. The horizontal red arrow indicates the mid‐parenteral height. Blue arrow indicates a delayed bone age of 4 years (at a chronological age of 6 years)</p>
</caption>
<graphic id="nlm-graphic-3" xlink:href="MGG3-8-e1086-g001"></graphic>
</fig>
<table-wrap id="mgg31086-tbl-0001" orientation="portrait" position="float" xml:lang="en">
<label>Table 1</label>
<caption>
<p>Biochemical investigations at time of diagnosis</p>
</caption>
<table frame="hsides" rules="groups">
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<tbody>
<tr>
<td align="left" colspan="4" rowspan="1">
<bold>Endocrinology</bold>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">Parameter</td>
<td align="left" colspan="1" rowspan="1">Result</td>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">Reference</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">HGH 30</td>
<td align="left" colspan="1" rowspan="1">0.16 μ/L</td>
<td align="left" colspan="1" rowspan="1">Low</td>
<td align="left" colspan="1" rowspan="1">7–10 μ/L</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">HGH 60</td>
<td align="left" colspan="1" rowspan="1">0.21 μ/L</td>
<td align="left" colspan="1" rowspan="1">Low</td>
<td align="left" colspan="1" rowspan="1">7–10 μ/L</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">HGH 90</td>
<td align="left" colspan="1" rowspan="1">0.18 μ/L</td>
<td align="left" colspan="1" rowspan="1">Low</td>
<td align="left" colspan="1" rowspan="1">7–10 μ/L</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">HGH baseline</td>
<td align="left" colspan="1" rowspan="1">0.17 μ/L</td>
<td align="left" colspan="1" rowspan="1">Low</td>
<td align="left" colspan="1" rowspan="1">7–10 μ/L</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">IGF1</td>
<td align="left" colspan="1" rowspan="1">46 μ/L</td>
<td align="left" colspan="1" rowspan="1">Low</td>
<td align="left" colspan="1" rowspan="1">85.2–249 μ/L</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">IGFBP−3</td>
<td align="left" colspan="1" rowspan="1">4.3 μ/L</td>
<td align="left" colspan="1" rowspan="1">Normal</td>
<td align="left" colspan="1" rowspan="1">1.6–6.5 μ/L</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">Glucagon</td>
<td align="left" colspan="1" rowspan="1">18 pg/mL</td>
<td align="left" colspan="1" rowspan="1">Normal</td>
<td align="left" colspan="1" rowspan="1">≤80 pg/Ml</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">TSH</td>
<td align="left" colspan="1" rowspan="1">0.22 mIU/L</td>
<td align="left" colspan="1" rowspan="1">Low</td>
<td align="left" colspan="1" rowspan="1">0.3–5 mIU/L</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">FT4</td>
<td align="left" colspan="1" rowspan="1">9.3 pmol/L</td>
<td align="left" colspan="1" rowspan="1">Low</td>
<td align="left" colspan="1" rowspan="1">11.58–18 pmol/L</td>
</tr>
<tr>
<td align="left" colspan="4" rowspan="1">
<bold>Immunology and autoimmune disease</bold>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">IgG</td>
<td align="left" colspan="1" rowspan="1">1,390 mg/dl</td>
<td align="left" colspan="1" rowspan="1">High</td>
<td align="left" colspan="1" rowspan="1">633–1280 mg/dl</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">IgA</td>
<td align="left" colspan="1" rowspan="1">251 mg/dl</td>
<td align="left" colspan="1" rowspan="1">High</td>
<td align="left" colspan="1" rowspan="1">33–202 mg/dl</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">Anti‐trasglutaminase IgA Ab</td>
<td align="left" colspan="1" rowspan="1">Negative</td>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">–</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="padding-left:10%">Anti‐trasglutaminase IgGAb</td>
<td align="left" colspan="1" rowspan="1">Negative</td>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">–</td>
</tr>
</tbody>
</table>
<permissions>
<copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
</permissions>
</table-wrap>
<fig fig-type="Figure" id="mgg31086-fig-0002" orientation="portrait" position="float" xml:lang="en">
<label>Figure 2</label>
<caption>
<p>MRI scan of the brain showing abnormal imaging, (a) hypoplasia of posterior pituitary gland. (b) hypoplasia sella with ectopic posterior pituitary gland</p>
</caption>
<graphic id="nlm-graphic-5" xlink:href="MGG3-8-e1086-g002"></graphic>
</fig>
</sec>
<sec id="mgg31086-sec-0007" sec-type="materials-and-methods">
<label>3</label>
<title>MATERIALS AND METHODS</title>
<sec id="mgg31086-sec-0008">
<label>3.1</label>
<title>Molecular karyotyping</title>
<p>DNA was extracted from a peripheral blood sample of the patient using QIAsymphony DSP DNA Kits according to the manufacturer's instructions. Genome‐wide copy number analysis was performed using an Affymetrix CytoScan 750K Array according to the manufacturer's instructions. Regions of copy number change were determined using the Affymetrix Chromosome Analysis Suite software (ChAS) v.3.2 and interpreted with the aid of the UCSC genome browser (<ext-link ext-link-type="uri" xlink:href="http://genome.ucsc.edu/">http://genome.ucsc.edu/</ext-link>; Human February 2009 GRCh37/hg19 assembly).</p>
<p>In the case of parental samples, 1 μg of DNA and opposite‐sex commercially available control DNA were labeled with Cy3‐ or Cy5‐deoxycytidine triphosphate, respectively, using Exo‐Klenow (OGT Cytosure Labeling Kit, catalogue no. 020020), and hybridized to a CytoSure ISCA 8 × 60 k array at 65°C for 18 hr. The array was washed and scanned with the Agilent High‐Resolution Microarray Scanner Model G2505B at 3‐µm resolution. Data analysis was performed using Feature Extraction version software from Agilent technologies and CytoSure Interpret Software (OGT).</p>
</sec>
<sec id="mgg31086-sec-0009">
<label>3.2</label>
<title>Conventional cytogenetics</title>
<p>A cytogenetic study was performed to characterize molecular karyotype findings. Chromosome analysis was performed according to standard procedures on metaphase cells obtained from short‐term culture of the peripheral blood sample. At least 20 metaphases were observed and analyzed by GTG banding with over 550 band resolution observed using ikaros software from metasystem. The karyotype was designated according to the International System for human Cytogenetic Nomenclature (ISCN).</p>
</sec>
<sec id="mgg31086-sec-0010">
<label>3.3</label>
<title>DNA sequencing</title>
<p>In the case of Sanger‐based sequencing, the mRNA sequence of the <italic>FOXA2</italic> was identified using the UCSC genome browser (<ext-link ext-link-type="uri" xlink:href="http://genome.ucsc.edu">http://genome.ucsc.edu</ext-link>). This website provides a direct link to ExonPrimer for the design of primers flanking coding exons. All primers were checked for single‐nucleotide polymorphisms (SNPs) using the software tool available from the National Genetic Reference Laboratory, Manchester (<ext-link ext-link-type="uri" xlink:href="https://ngrl.manchester.ac.uk/SNPCheckV3/snpcheck.htm">https://ngrl.manchester.ac.uk/SNPCheckV3/snpcheck.htm</ext-link>). The primers were tailed with M13 sequences and were synthesized by Invitrogen Ltd.</p>
<p>PCR was performed using 1U Faststart Taq DNA polymerase (Invitrogen Ltd), 50 ng genomic DNA, 2‐mM MgCl2, 0.8‐μM forward and reverse primers, with the following cycle conditions: 95°C for 4 min, 35 cycles of 94°C for 45s, 60°C for 30 s, 72°C for 30 s, and a final extension at 72°C for 10min. All amplicons amplified efficiently under these conditions. Five microliter of each PCR was cleaned with ExoSAP‐IT (Affymetrix) prior to bidirectional DNA sequencing using M13 forward and reverse primers and Big‐Dye Terminator v3.0 (Applied Biosystems Ltd). Twenty microliter of sequenced product was purified using Clean‐Seq (Agencourt). Fifteen microliter of purified product was then subjected to capillary electrophoresis using an Applied Biosystems model 3500 Genetic Analyzer. Sequencing analysis software v6.0 and SeqScape software v3.0 were used for Sanger sequencing analysis (Applied Biosystems, Cat No.: 4474978).</p>
<p>In the case of whole genome sequencing (WGS), DNA was extracted from blood from the patient and his parents. As a first step, the extracted DNA was subjected to WGS using an Illumina HiSeqX platform and a 150‐base paired‐end single‐index‐read format. This method yielded two FASTQ files that contained the nucleotide sequence reads and quality scores for each sample. Genome Analysis Toolkit (GATK) version 3.6 was used to further process the FASTQ files in order to identify variants in the patient and parents. FastQC (version 0.11.2) software was run on the raw data, together with combinations of SAM Tools (version 1.7). Burrows–Wheeler Aligner 0.7.8 (BWA‐MEM) was used to map the sequence reads to the NCBI human reference genome GRGh37/hg19. Variants were then called using the GATK tools which produce a variant call format (VCF) file that gives information on SNPs, indels (insertion or deletions), and other structural variants in the samples that were processed.</p>
</sec>
</sec>
<sec id="mgg31086-sec-0011" sec-type="results">
<label>4</label>
<title>RESULTS</title>
<sec id="mgg31086-sec-0012">
<label>4.1</label>
<title>Molecular karyotype</title>
<p>Molecular karyotype analysis of the proband showed a male profile with an interstitial deletion of the short arm of chromosome 20: arr[hg19] 20p11.22p11.21(21881142–22850635)X1. The deletion of ~969 kb contains only one OMIM gene: <italic>FOXA2</italic>. Each parent had a normal molecular karyotype profile suggesting the deletion observed in our patient was de novo.</p>
</sec>
<sec id="mgg31086-sec-0013">
<label>4.2</label>
<title>Conventional cytogenetics</title>
<p>G‐banding chromosome analysis of 20 cells from a peripheral blood sample of the proband revealed a male chromosome complement with a reciprocal translocation between the short arm of chromosome 6 and 20, karyotype: [46 XY, t (6; 20) (p11;p11)] (Figure <xref ref-type="fig" rid="mgg31086-fig-0003">3</xref>). Each parent had a normal karyotype.</p>
<fig fig-type="Figure" id="mgg31086-fig-0003" orientation="portrait" position="float" xml:lang="en">
<label>Figure 3</label>
<caption>
<p>Conventional karyotyping revealing translocation between chromosome 6 and 20. a) A male karyotyping with t(6;20)(p11.2;p11.2). b) Partial karyotype showing t(6;20)(p11.2;p11.2)</p>
</caption>
<graphic id="nlm-graphic-7" xlink:href="MGG3-8-e1086-g003"></graphic>
</fig>
</sec>
<sec id="mgg31086-sec-0014">
<label>4.3</label>
<title>DNA Sequencing</title>
<p>Sanger‐based sequence analysis showed no variants in the coding regions of the <italic>FOXA2</italic> of our patient compared to controls and the human genome reference.</p>
<p>We undertook WGS analysis of our patient, together with parental samples, with a focus on those genes implicated in combined pituitary hormone deficiency, GH deficiency, and hypothyroidism. The gene list was constructed by searching a number of databases: NCBI dbSNP, ClinVar, 1000 genome, Human Genome Variation Society (HGVS), and Ensembl. No pathogenic or likely pathogenic single nucleotide variants were detected in our patient, or his parents. A screen for copy number variants (CNVs) identified a large deletion encompassing the <italic>FOXA2</italic> with a depth of coverage of 15X in our patient compared to an average of 30X, suggesting a heterozygous deletion of the <italic>FOXA2</italic>. No obvious CNVs were detected in chr6p11.</p>
</sec>
</sec>
<sec id="mgg31086-sec-0015" sec-type="discussion">
<label>5</label>
<title>DISCUSSION</title>
<p>Most of the previously reported deletions of chromosome 20 short arm, involving the 20p11.2 region, are associated with Alagille syndrome. This deleted region includes the <italic>JAG1</italic>. Alagille syndrome is inherited in an autosomal dominant manner and affects various organs with variable severity due to variable expressivity (Anad et al., <xref ref-type="ref" rid="mgg31086-bib-0001">1990</xref>; Elmslie et al., <xref ref-type="ref" rid="mgg31086-bib-0006">1995</xref>).</p>
<p>Our patient's genotype at the whole genome level was characterized as 46, XY,t(6;20)(p11.2;p11.2) and arr[hg19] 20p11.22p11.21(21881142–22850635)X1. The deletion only encompasses the <italic>FOXA2</italic>. The main phenotypes associated with deletions in this region are panhypopituitarism and GH deficiency. Five of the eight reported cases overlapping with our case presented with panhypopituitarism (Dayem‐Quere et al., <xref ref-type="ref" rid="mgg31086-bib-0005">2013</xref>; Kale et al., <xref ref-type="ref" rid="mgg31086-bib-0017">2017</xref>; Tsai et al., <xref ref-type="ref" rid="mgg31086-bib-0024">2015</xref>; Williams, Wetherbee, Rosenfeld, &amp; Hersh, <xref ref-type="ref" rid="mgg31086-bib-0028">2011</xref>). Our patient had severe GH deficiency and central hypothyroidism that required treatment (levothyroxine and GH therapy). It is not surprising that patients who were reported earlier (Garcia‐Heras et al., <xref ref-type="ref" rid="mgg31086-bib-0010">2005</xref>; Kamath et al., <xref ref-type="ref" rid="mgg31086-bib-0018">2009</xref>; Tsai et al., <xref ref-type="ref" rid="mgg31086-bib-0024">2015</xref>) presented with GH deficiency and shared a deleted region partially overlapping with our case (Table <xref ref-type="table" rid="mgg31086-tbl-0002">2</xref>).</p>
<table-wrap id="mgg31086-tbl-0002" orientation="portrait" position="float" xml:lang="en">
<label>Table 2</label>
<caption>
<p>Genomic coordinates in our patient and previously reported case of chromosome 20p deletion (GRCH37, hg19)</p>
</caption>
<table frame="hsides" rules="groups">
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<thead valign="top">
<tr style="border-bottom:solid 1px #000000">
<th align="left" colspan="1" rowspan="1" valign="top">Authors</th>
<th align="left" colspan="2" rowspan="1" style="border-bottom:solid 1px #000000" valign="top">hg19 coordinates</th>
</tr>
<tr style="border-bottom:solid 1px #000000">
<th align="left" colspan="1" rowspan="1" valign="top">This patient</th>
<th align="left" colspan="1" rowspan="1" valign="top">21881142</th>
<th align="left" colspan="1" rowspan="1" valign="top">22850635</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Dayem‐Quere et al., <xref ref-type="ref" rid="mgg31086-bib-0005">2013</xref>
</td>
<td align="left" colspan="1" rowspan="1">19810034</td>
<td align="left" colspan="1" rowspan="1">24031344</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Garcia‐Heras et al., <xref ref-type="ref" rid="mgg31086-bib-0010">2005</xref>
</td>
<td align="left" colspan="1" rowspan="1">No MKAR data, only G‐banding: 20p11.1−20p12</td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Kale et al., <xref ref-type="ref" rid="mgg31086-bib-0017">2017</xref>
</td>
<td align="left" colspan="1" rowspan="1">
<p>(build 36) hg18: 15841592</p>
<p>15893592</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>Build 36 (hg18): 24189610</p>
<p>24241610</p>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Kamath et al., <xref ref-type="ref" rid="mgg31086-bib-0018">2009</xref>
</td>
<td align="left" colspan="1" rowspan="1">
<p>13618382 (build 35/hg17: 13566382)</p>
<p>14352641 (build 35/hg17: 14300641)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>22303261 (build 35/hg17: 22251261)</p>
<p>26309255 (build 35/hg17: 26257255)</p>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Laufer‐Cahana et al., <xref ref-type="ref" rid="mgg31086-bib-0021">2002</xref>
</td>
<td align="left" colspan="1" rowspan="1">No MKAR data, only G‐banding</td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Michaelis et al., <xref ref-type="ref" rid="mgg31086-bib-0022">1997</xref>
</td>
<td align="left" colspan="1" rowspan="1">
<p>D20S80 not deleted:</p>
<p>D20S104 deleted: 16187053</p>
<p>16187053</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>PCSK2 deleted: 17465222</p>
<p>D20S40 not deleted</p>
<p>17465222</p>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Tsai et al., <xref ref-type="ref" rid="mgg31086-bib-0024">2015</xref>
</td>
<td align="left" colspan="1" rowspan="1">22496147</td>
<td align="left" colspan="1" rowspan="1">22773103</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Williams et al., <xref ref-type="ref" rid="mgg31086-bib-0028">2011</xref>
</td>
<td align="left" colspan="1" rowspan="1">
<p>(build 36) hg18: 19149641</p>
<p>19201641</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>(build36) hg18: 24569358</p>
<p>24621358</p>
</td>
</tr>
</tbody>
</table>
<permissions>
<copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
</permissions>
</table-wrap>
<p>Recently, de novo heterozygous <italic>FOXA2</italic> mutations have been reported in patients with the clinical phenotype of congenital hypopituitarism, hyperinsulinism, hypoglycemia, and endometrial‐derived organ abnormalities (Giri et al., <xref ref-type="ref" rid="mgg31086-bib-0011">2017</xref>; Tsai et al., <xref ref-type="ref" rid="mgg31086-bib-0024">2015</xref>; Vajravelu et al., <xref ref-type="ref" rid="mgg31086-bib-0025">2018</xref>). Our patient shares most of these phenotypes except that our patient does not exhibit hyperinsulinemic hypoglycemia. A recent report identified a de novo heterozygous mutation in the <italic>FOXA2</italic>, c.664T&gt; G (p.Cys222Gly), in a patient with intestinal malrotation, anal atresia, and pituitary hormone deficiency (Boda et al., <xref ref-type="ref" rid="mgg31086-bib-0004">2018</xref>; Figure <xref ref-type="fig" rid="mgg31086-fig-0004">4</xref>).</p>
<fig fig-type="Figure" id="mgg31086-fig-0004" orientation="portrait" position="float" xml:lang="en">
<label>Figure 4</label>
<caption>
<p>Location and extent of microdeletions reported in chr20p11.23–11.21. (a) Shows an ideogram of chromosome 20. (b) Shows the location and extent of the deletions detected in the patient described here, and other cases reported in the literature, as well as Refseq genes that lie within the shown region. In the case of the deletions shown for patient 19 reported by Kamath et al. (<xref ref-type="ref" rid="mgg31086-bib-0018">2009</xref>), and the deletion shown for the patient reported by Kale et al. (<xref ref-type="ref" rid="mgg31086-bib-0017">2017</xref>), these extend further distally, while the deletion shown for patient 20 reported by Kamath et al. (<xref ref-type="ref" rid="mgg31086-bib-0018">2009</xref>) extends both proximally as well as distally. These graphics were <named-content content-type="attribution">taken from </named-content>the UCSC genome browser (<ext-link ext-link-type="uri" xlink:href="http://genome.ucsc.edu/">http://genome.ucsc.edu/</ext-link>)</p>
</caption>
<graphic id="nlm-graphic-9" xlink:href="MGG3-8-e1086-g004"></graphic>
</fig>
<p>To understand if our patient had any hypoglycemia, we undertook continuous glucose monitoring in our patient for 7 days and there was no hypoglycemia. The patient also fasted for 18 hr with no hypoglycemia and appropriate increases in serum fatty acids and ketone bodies. Similarly, the serum glucagon concentration of our patient was within the normal reference range. These results of the glucose and glucagon levels suggest that one copy of <italic>FOXA2</italic> may be sufficient to maintain normal blood glucose, insulin, and glucagon levels. However, it is unclear if the intellectual, developmental, and metabolic status of the child may change with age.</p>
</sec>
<sec id="mgg31086-sec-0016" sec-type="conclusions">
<label>6</label>
<title>CONCLUSIONS</title>
<p>Our patient is the first reported case of an unbalanced t(6;20) translocation carrying a small chr20p deletion involving only the <italic>FOXA2</italic>, and exhibiting features related to GH deficiency and hypothyroidism (Figure <xref ref-type="fig" rid="mgg31086-fig-0005">5</xref>). Our patient's clinical findings, together with previously reported cases, suggest that haploinsufficiency of <italic>FOXA2</italic> has implications in panhypopituitarism and GH deficiency. Panhypopituitarism may be the most common feature represented in heterozygous 20p deletions caused by the shallow and underdeveloped sella and pituitary hormonal deficiency. Patients with heterozygous <italic>FOXA2</italic> mutations appear to exhibit hyperinsulinemia and hypoglycemia. Our patient has not manifested any changes in blood glucose, glucagon, or insulin levels, but he may develop later‐onset diabetes. It is possible that the complete loss of <italic>FOXA2</italic> affects the pancreas and glucose levels, whereas haploinsufficiency of <italic>FOXA2</italic> affects mainly the pituitary gland.</p>
<fig fig-type="Figure" id="mgg31086-fig-0005" orientation="portrait" position="float" xml:lang="en">
<label>Figure 5</label>
<caption>
<p>Factors that stimulate and suppress GH secretion under physiological conditions. Green indicates stimulation and red indicates inhibition. In the patient, <italic>FOXA2</italic> deletion lead to growth hormone deficiency, hypothyroidism, and reduced weight gain. TSH: Thyroid‐stimulating hormone; FFA: Free fatty acid; IGF1: Insulin‐like growth factor‐1; SS: Somatostatin; GHRH: Growth hormone–releasing hormone</p>
</caption>
<graphic id="nlm-graphic-11" xlink:href="MGG3-8-e1086-g005"></graphic>
</fig>
<p>Studying the signaling pathways affected by the heterozygous loss of <italic>FOXA2,</italic> as well as identifying the upstream and downstream protein partners of <italic>FOXA2</italic>, may allow an understanding of how <italic>FOXA2</italic> haploinsufficiency leads to GH deficiency and hypopituitarism.</p>
</sec>
<sec id="mgg31086-sec-0017">
<title>ETHICS STATEMENT</title>
<p>Written informed consent was obtained from the parents of the patient for the participation in the study and the publication of this case report and accompanying images. A copy of the written consents from both parents is available for review by the editor of this journal.</p>
</sec>
<sec id="mgg31086-sec-0019" sec-type="COI-statement">
<title>CONFLICT OF INTEREST</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</body>
<back>
<ack id="mgg31086-sec-0018">
<title>ACKNOWLEDGMENT</title>
<p>We thank the patient and his family for actively participating in this study.</p>
</ack>
<ref-list content-type="cited-references" id="mgg31086-bibl-0001">
<title>REFERENCES</title>
<ref id="mgg31086-bib-0001">
<mixed-citation id="mgg31086-cit-0001" publication-type="journal">
<string-name>
<surname>Anad</surname>, <given-names>F.</given-names>
</string-name>, <string-name>
<surname>Burn</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Matthews</surname>, <given-names>D.</given-names>
</string-name>, <string-name>
<surname>Cross</surname>, <given-names>I.</given-names>
</string-name>, <string-name>
<surname>Davison</surname>, <given-names>B. C.</given-names>
</string-name>, <string-name>
<surname>Mueller</surname>, <given-names>R.</given-names>
</string-name>, … <string-name>
<surname>Eastham</surname>, <given-names>E.</given-names>
</string-name> (<year>1990</year>). <article-title>Alagille syndrome and deletion of 20p</article-title>. <source xml:lang="en"/>Journal of Medical Genetics, <volume>27</volume>(<issue>12</issue>), <fpage>729</fpage>–<lpage>737</lpage>. <pub-id pub-id-type="doi">10.1136/jmg.27.12.729</pub-id>
<pub-id pub-id-type="pmid">2074558</pub-id></mixed-citation>
</ref>
<ref id="mgg31086-bib-0002">
<mixed-citation id="mgg31086-cit-0002" publication-type="journal">
<string-name>
<surname>Ang</surname>, <given-names>S. L.</given-names>
</string-name>, &amp; <string-name>
<surname>Rossant</surname>, <given-names>J.</given-names>
</string-name> (<year>1994</year>). <article-title>HNF‐3 beta is essential for node and notochord formation in mouse development</article-title>. <source xml:lang="en"/>Cell, <volume>78</volume>(<issue>4</issue>), <fpage>561</fpage>–<lpage>574</lpage>. <pub-id pub-id-type="doi">10.1016/0092-8674(94)90522-3</pub-id>
<pub-id pub-id-type="pmid">8069909</pub-id></mixed-citation>
</ref>
<ref id="mgg31086-bib-0003">
<mixed-citation id="mgg31086-cit-0003" publication-type="journal">
<string-name>
<surname>Besnard</surname>, <given-names>V.</given-names>
</string-name>, <string-name>
<surname>Wert</surname>, <given-names>S. E.</given-names>
</string-name>, <string-name>
<surname>Hull</surname>, <given-names>W. M.</given-names>
</string-name>, &amp; <string-name>
<surname>Whitsett</surname>, <given-names>J. A.</given-names>
</string-name> (<year>2004</year>). <article-title>Immunohistochemical localization of Foxa1 and Foxa2 in mouse embryos and adult tissues</article-title>. <source xml:lang="en"/>Gene Expression Patterns, <volume>5</volume>(<issue>2</issue>), <fpage>193</fpage>–<lpage>208</lpage>. <pub-id pub-id-type="doi">10.1016/j.modgep.2004.08.006</pub-id>
<pub-id pub-id-type="pmid">15567715</pub-id></mixed-citation>
</ref>
<ref id="mgg31086-bib-0004">
<mixed-citation id="mgg31086-cit-0004" publication-type="journal">
<string-name>
<surname>Boda</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<surname>Miyata</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Inagaki</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<surname>Shinkai</surname>, <given-names>Y.</given-names>
</string-name>, <string-name>
<surname>Kato</surname>, <given-names>T.</given-names>
</string-name>, <string-name>
<surname>Yoshikawa</surname>, <given-names>T.</given-names>
</string-name>, &amp; <string-name>
<surname>Kurahashi</surname>, <given-names>H.</given-names>
</string-name> (<year>2018</year>). <article-title>FOXA2 gene mutation in a patient with congenital complex pituitary hormone deficiency</article-title>. <source xml:lang="en"/>European Journal of Medical Genetics, <pub-id pub-id-type="doi">10.1016/j.ejmg.2018.11.004</pub-id>
</mixed-citation>
</ref>
<ref id="mgg31086-bib-0005">
<mixed-citation id="mgg31086-cit-0005" publication-type="journal">
<string-name>
<surname>Dayem‐Quere</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Giuliano</surname>, <given-names>F.</given-names>
</string-name>, <string-name>
<surname>Wagner‐Mahler</surname>, <given-names>K.</given-names>
</string-name>, <string-name>
<surname>Massol</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Crouzet‐Ozenda</surname>, <given-names>L.</given-names>
</string-name>, <string-name>
<surname>Lambert</surname>, <given-names>J. C.</given-names>
</string-name>, &amp; <string-name>
<surname>Karmous‐Benailly</surname>, <given-names>H.</given-names>
</string-name> (<year>2013</year>). <article-title>Delineation of a region responsible for panhypopituitarism in 20p11.2</article-title>. <source xml:lang="en"/>American Journal of Medical Genetics. Part A, <volume>161a</volume>(<issue>7</issue>), <fpage>1547</fpage>–<lpage>1554</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.35921</pub-id>
<pub-id pub-id-type="pmid">23657910</pub-id></mixed-citation>
</ref>
<ref id="mgg31086-bib-0006">
<mixed-citation id="mgg31086-cit-0006" publication-type="journal">
<string-name>
<surname>Elmslie</surname>, <given-names>F. V.</given-names>
</string-name>, <string-name>
<surname>Vivian</surname>, <given-names>A. J.</given-names>
</string-name>, <string-name>
<surname>Gardiner</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<surname>Hall</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Mowat</surname>, <given-names>A. P.</given-names>
</string-name>, &amp; <string-name>
<surname>Winter</surname>, <given-names>R. M.</given-names>
</string-name> (<year>1995</year>). <article-title>Alagille syndrome: Family studies</article-title>. <source xml:lang="en"/>Journal of Medical Genetics, <volume>32</volume>(<issue>4</issue>), <fpage>264</fpage>–<lpage>268</lpage>. <pub-id pub-id-type="doi">10.1136/jmg.32.4.264</pub-id>
<pub-id pub-id-type="pmid">7643353</pub-id></mixed-citation>
</ref>
<ref id="mgg31086-bib-0007">
<mixed-citation id="mgg31086-cit-0007" publication-type="journal">
<string-name>
<surname>Friedman</surname>, <given-names>J. R.</given-names>
</string-name>, &amp; <string-name>
<surname>Kaestner</surname>, <given-names>K. H.</given-names>
</string-name> (<year>2006</year>). <article-title>The Foxa family of transcription factors in development and metabolism</article-title>. <source xml:lang="en"/>Cellular and Molecular Life Sciences, <volume>63</volume>(<issue>19–20</issue>), <fpage>2317</fpage>–<lpage>2328</lpage>. <pub-id pub-id-type="doi">10.1007/s00018-006-6095-6</pub-id>
<pub-id pub-id-type="pmid">16909212</pub-id></mixed-citation>
</ref>
<ref id="mgg31086-bib-0008">
<mixed-citation id="mgg31086-cit-0008" publication-type="journal">
<string-name>
<surname>Gao</surname>, <given-names>N.</given-names>
</string-name>, <string-name>
<surname>Le Lay</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Qin</surname>, <given-names>W.</given-names>
</string-name>, <string-name>
<surname>Doliba</surname>, <given-names>N.</given-names>
</string-name>, <string-name>
<surname>Schug</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Fox</surname>, <given-names>A. J.</given-names>
</string-name>, … <string-name>
<surname>Kaestner</surname>, <given-names>K. H.</given-names>
</string-name> (<year>2010</year>). <article-title>Foxa1 and Foxa2 maintain the metabolic and secretory features of the mature beta‐cell</article-title>. <source xml:lang="en"/>Molecular Endocrinology, <volume>24</volume>(<issue>8</issue>), <fpage>1594</fpage>–<lpage>1604</lpage>. <pub-id pub-id-type="doi">10.1210/me.2009-0513</pub-id>
<pub-id pub-id-type="pmid">20534694</pub-id></mixed-citation>
</ref>
<ref id="mgg31086-bib-0009">
<mixed-citation id="mgg31086-cit-0009" publication-type="journal">
<string-name>
<surname>Gao</surname>, <given-names>N.</given-names>
</string-name>, <string-name>
<surname>LeLay</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Vatamaniuk</surname>, <given-names>M. Z.</given-names>
</string-name>, <string-name>
<surname>Rieck</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Friedman</surname>, <given-names>J. R.</given-names>
</string-name>, &amp; <string-name>
<surname>Kaestner</surname>, <given-names>K. H.</given-names>
</string-name> (<year>2008</year>). <article-title>Dynamic regulation of Pdx1 enhancers by Foxa1 and Foxa2 is essential for pancreas development</article-title>. <source xml:lang="en"/>Genes &amp; Development, <volume>22</volume>(<issue>24</issue>), <fpage>3435</fpage>–<lpage>3448</lpage>. <pub-id pub-id-type="doi">10.1101/gad.1752608</pub-id>
<pub-id pub-id-type="pmid">19141476</pub-id></mixed-citation>
</ref>
<ref id="mgg31086-bib-0010">
<mixed-citation id="mgg31086-cit-0010" publication-type="journal">
<string-name>
<surname>Garcia‐Heras</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Kilani</surname>, <given-names>R. A.</given-names>
</string-name>, <string-name>
<surname>Martin</surname>, <given-names>R. A.</given-names>
</string-name>, &amp; <string-name>
<surname>Lamp</surname>, <given-names>S.</given-names>
</string-name> (<year>2005</year>). <article-title>A deletion of proximal 20p inherited from a normal mosaic carrier mother in a newborn with panhypopituitarism and craniofacial dysmorphism</article-title>. <source xml:lang="en"/>Clinical Dysmorphology, <volume>14</volume>(<issue>3</issue>), <fpage>137</fpage>–<lpage>140</lpage>. <pub-id pub-id-type="doi">10.1097/00019605-200507000-00006</pub-id>
<pub-id pub-id-type="pmid">15930903</pub-id></mixed-citation>
</ref>
<ref id="mgg31086-bib-0011">
<mixed-citation id="mgg31086-cit-0011" publication-type="journal">
<string-name>
<surname>Giri</surname>, <given-names>D.</given-names>
</string-name>, <string-name>
<surname>Vignola</surname>, <given-names>M. L.</given-names>
</string-name>, <string-name>
<surname>Gualtieri</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Scagliotti</surname>, <given-names>V.</given-names>
</string-name>, <string-name>
<surname>McNamara</surname>, <given-names>P.</given-names>
</string-name>, <string-name>
<surname>Peak</surname>, <given-names>M.</given-names>
</string-name>, … <string-name>
<surname>Senniappan</surname>, <given-names>S.</given-names>
</string-name> (<year>2017</year>). <article-title>Novel FOXA2 mutation causes hyperinsulinism, hypopituitarism with craniofacial and endoderm‐derived organ abnormalities</article-title>. <source xml:lang="en"/>Human Molecular Genetics, <volume>26</volume>(<issue>22</issue>), <fpage>4315</fpage>–<lpage>4326</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddx318</pub-id>
<pub-id pub-id-type="pmid">28973288</pub-id></mixed-citation>
</ref>
<ref id="mgg31086-bib-0012">
<mixed-citation id="mgg31086-cit-0012" publication-type="journal">
<string-name>
<surname>Goldman</surname>, <given-names>M.</given-names>
</string-name>, &amp; <string-name>
<surname>Pranikoff</surname>, <given-names>T.</given-names>
</string-name> (<year>2011</year>). <article-title>Biliary disease in children</article-title>. <source xml:lang="en"/>Current Gastroenterology Reports, <volume>13</volume>(<issue>2</issue>), <fpage>193</fpage>–<lpage>201</lpage>. <pub-id pub-id-type="doi">10.1007/s11894-010-0169-1</pub-id>
<pub-id pub-id-type="pmid">21225381</pub-id></mixed-citation>
</ref>
<ref id="mgg31086-bib-0013">
<mixed-citation id="mgg31086-cit-0013" publication-type="journal">
<string-name>
<surname>Guegan</surname>, <given-names>K.</given-names>
</string-name>, <string-name>
<surname>Stals</surname>, <given-names>K.</given-names>
</string-name>, <string-name>
<surname>Day</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Turnpenny</surname>, <given-names>P.</given-names>
</string-name>, &amp; <string-name>
<surname>Ellard</surname>, <given-names>S.</given-names>
</string-name> (<year>2012</year>). <article-title>JAG1 mutations are found in approximately one third of patients presenting with only one or two clinical features of Alagille syndrome</article-title>. <source xml:lang="en"/>Clinical Genetics, <volume>82</volume>(<issue>1</issue>), <fpage>33</fpage>–<lpage>40</lpage>. <pub-id pub-id-type="doi">10.1111/j.1399-0004.2011.01749.x</pub-id>
<pub-id pub-id-type="pmid">21752016</pub-id></mixed-citation>
</ref>
<ref id="mgg31086-bib-0014">
<mixed-citation id="mgg31086-cit-0014" publication-type="journal">
<string-name>
<surname>Heddad Masson</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Poisson</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Guerardel</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Mamin</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Philippe</surname>, <given-names>J.</given-names>
</string-name>, &amp; <string-name>
<surname>Gosmain</surname>, <given-names>Y.</given-names>
</string-name> (<year>2014</year>). <article-title>Foxa1 and Foxa2 regulate alpha‐cell differentiation, glucagon biosynthesis, and secretion</article-title>. <source xml:lang="en"/>Endocrinology, <volume>155</volume>(<issue>10</issue>), <fpage>3781</fpage>–<lpage>3792</lpage>. <pub-id pub-id-type="doi">10.1210/en.2013-1843</pub-id>
<pub-id pub-id-type="pmid">25057789</pub-id></mixed-citation>
</ref>
<ref id="mgg31086-bib-0015">
<mixed-citation id="mgg31086-cit-0015" publication-type="journal">
<string-name>
<surname>Kaestner</surname>, <given-names>K. H.</given-names>
</string-name> (<year>2000</year>). <article-title>The hepatocyte nuclear factor 3 (HNF3 or FOXA) family in metabolism</article-title>. <source xml:lang="en"/>Trends in Endocrinology and Metabolism, <volume>11</volume>(<issue>7</issue>), <fpage>281</fpage>–<lpage>285</lpage>. <pub-id pub-id-type="doi">10.1016/S1043-2760(00)00271-X</pub-id>
<pub-id pub-id-type="pmid">10920385</pub-id></mixed-citation>
</ref>
<ref id="mgg31086-bib-0016">
<mixed-citation id="mgg31086-cit-0016" publication-type="journal">
<string-name>
<surname>Kaestner</surname>, <given-names>K. H.</given-names>
</string-name> (<year>2010</year>). <article-title>The FoxA factors in organogenesis and differentiation</article-title>. <source xml:lang="en"/>Current Opinion in Genetics &amp; Development, <volume>20</volume>(<issue>5</issue>), <fpage>527</fpage>–<lpage>532</lpage>. <pub-id pub-id-type="doi">10.1016/j.gde.2010.06.005</pub-id>
<pub-id pub-id-type="pmid">20591647</pub-id></mixed-citation>
</ref>
<ref id="mgg31086-bib-0017">
<mixed-citation id="mgg31086-cit-0017" publication-type="journal">
<string-name>
<surname>Kale</surname>, <given-names>T.</given-names>
</string-name>, <string-name>
<surname>Patil</surname>, <given-names>R.</given-names>
</string-name>, &amp; <string-name>
<surname>Pandit</surname>, <given-names>R.</given-names>
</string-name> (<year>2017</year>). <article-title>A newborn with panhypopituitarism and seizures</article-title>. <source xml:lang="en"/>Case Reports in Genetics, <volume>2017</volume>, <fpage>1</fpage>–<lpage>3</lpage>. <pub-id pub-id-type="doi">10.1155/2017/4364216</pub-id>
</mixed-citation>
</ref>
<ref id="mgg31086-bib-0018">
<mixed-citation id="mgg31086-cit-0018" publication-type="journal">
<string-name>
<surname>Kamath</surname>, <given-names>B. M.</given-names>
</string-name>, <string-name>
<surname>Thiel</surname>, <given-names>B. D.</given-names>
</string-name>, <string-name>
<surname>Gai</surname>, <given-names>X.</given-names>
</string-name>, <string-name>
<surname>Conlin</surname>, <given-names>L. K.</given-names>
</string-name>, <string-name>
<surname>Munoz</surname>, <given-names>P. S.</given-names>
</string-name>, <string-name>
<surname>Glessner</surname>, <given-names>J.</given-names>
</string-name>, … <string-name>
<surname>Spinner</surname>, <given-names>N. B.</given-names>
</string-name> (<year>2009</year>). <article-title>SNP array mapping of chromosome 20p deletions: Genotypes, phenotypes, and copy number variation</article-title>. <source xml:lang="en"/>Human Mutation, <volume>30</volume>(<issue>3</issue>), <fpage>371</fpage>–<lpage>378</lpage>. <pub-id pub-id-type="doi">10.1002/humu.20863</pub-id>
<pub-id pub-id-type="pmid">19058200</pub-id></mixed-citation>
</ref>
<ref id="mgg31086-bib-0019">
<mixed-citation id="mgg31086-cit-0019" publication-type="journal">
<string-name>
<surname>Kelleher</surname>, <given-names>A. M.</given-names>
</string-name>, <string-name>
<surname>Peng</surname>, <given-names>W.</given-names>
</string-name>, <string-name>
<surname>Pru</surname>, <given-names>J. K.</given-names>
</string-name>, <string-name>
<surname>Pru</surname>, <given-names>C. A.</given-names>
</string-name>, <string-name>
<surname>DeMayo</surname>, <given-names>F. J.</given-names>
</string-name>, &amp; <string-name>
<surname>Spencer</surname>, <given-names>T. E.</given-names>
</string-name> (<year>2017</year>). <article-title>Forkhead box a2 (FOXA2) is essential for uterine function and fertility</article-title>. <source xml:lang="en"/>Proceedings of the National Academy of Sciences of the United States of America, <volume>114</volume>(<issue>6</issue>), <fpage>E1018</fpage>–<lpage>E1026</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1618433114</pub-id>
<pub-id pub-id-type="pmid">28049832</pub-id></mixed-citation>
</ref>
<ref id="mgg31086-bib-0020">
<mixed-citation id="mgg31086-cit-0020" publication-type="journal">
<string-name>
<surname>Lantz</surname>, <given-names>K. A.</given-names>
</string-name>, <string-name>
<surname>Vatamaniuk</surname>, <given-names>M. Z.</given-names>
</string-name>, <string-name>
<surname>Brestelli</surname>, <given-names>J. E.</given-names>
</string-name>, <string-name>
<surname>Friedman</surname>, <given-names>J. R.</given-names>
</string-name>, <string-name>
<surname>Matschinsky</surname>, <given-names>F. M.</given-names>
</string-name>, &amp; <string-name>
<surname>Kaestner</surname>, <given-names>K. H.</given-names>
</string-name> (<year>2004</year>). <article-title>Foxa2 regulates multiple pathways of insulin secretion</article-title>. <source xml:lang="en"/>Journal of Clinical Investigation, <volume>114</volume>(<issue>4</issue>), <fpage>512</fpage>–<lpage>520</lpage>. <pub-id pub-id-type="doi">10.1172/jci21149</pub-id>
<pub-id pub-id-type="pmid">15314688</pub-id></mixed-citation>
</ref>
<ref id="mgg31086-bib-0021">
<mixed-citation id="mgg31086-cit-0021" publication-type="journal">
<string-name>
<surname>Laufer‐Cahana</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Krantz</surname>, <given-names>I. D.</given-names>
</string-name>, <string-name>
<surname>Bason</surname>, <given-names>L. D.</given-names>
</string-name>, <string-name>
<surname>Lu</surname>, <given-names>F. M.</given-names>
</string-name>, <string-name>
<surname>Piccoli</surname>, <given-names>D. A.</given-names>
</string-name>, &amp; <string-name>
<surname>Spinner</surname>, <given-names>N. B.</given-names>
</string-name> (<year>2002</year>). <article-title>Alagille syndrome inherited from a phenotypically normal mother with a mosaic 20p microdeletion</article-title>. <source xml:lang="en"/>American Journal of Medical Genetics, <volume>112</volume>(<issue>2</issue>), <fpage>190</fpage>–<lpage>193</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.10616</pub-id>
<pub-id pub-id-type="pmid">12244554</pub-id></mixed-citation>
</ref>
<ref id="mgg31086-bib-0022">
<mixed-citation id="mgg31086-cit-0022" publication-type="journal">
<string-name>
<surname>Michaelis</surname>, <given-names>R. C.</given-names>
</string-name>, <string-name>
<surname>Skinner</surname>, <given-names>S. A.</given-names>
</string-name>, <string-name>
<surname>Deason</surname>, <given-names>R.</given-names>
</string-name>, <string-name>
<surname>Skinner</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Moore</surname>, <given-names>C. L.</given-names>
</string-name>, &amp; <string-name>
<surname>Phelan</surname>, <given-names>M. C.</given-names>
</string-name> (<year>1997</year>). <article-title>Intersitial deletion of 20p: New candidate region for Hirschsprung disease and autism?</article-title>
<source xml:lang="en"/>American Journal of Medical Genetics, <volume>71</volume>(<issue>3</issue>), <fpage>298</fpage>–<lpage>304</lpage>. <pub-id pub-id-type="doi">10.1002/(SICI)1096-8628(19970822)71:3&lt;298:AID-AJMG10&gt;3.0.CO;2-F</pub-id>
<pub-id pub-id-type="pmid">9268100</pub-id></mixed-citation>
</ref>
<ref id="mgg31086-bib-0023">
<mixed-citation id="mgg31086-cit-0023" publication-type="journal">
<string-name>
<surname>Sund</surname>, <given-names>N. J.</given-names>
</string-name>, <string-name>
<surname>Vatamaniuk</surname>, <given-names>M. Z.</given-names>
</string-name>, <string-name>
<surname>Casey</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Ang</surname>, <given-names>S. L.</given-names>
</string-name>, <string-name>
<surname>Magnuson</surname>, <given-names>M. A.</given-names>
</string-name>, <string-name>
<surname>Stoffers</surname>, <given-names>D. A.</given-names>
</string-name>, … <string-name>
<surname>Kaestner</surname>, <given-names>K. H.</given-names>
</string-name> (<year>2001</year>). <article-title>Tissue‐specific deletion of Foxa2 in pancreatic beta cells results in hyperinsulinemic hypoglycemia</article-title>. <source xml:lang="en"/>Genes &amp; Development, <volume>15</volume>(<issue>13</issue>), <fpage>1706</fpage>–<lpage>1715</lpage>. <pub-id pub-id-type="doi">10.1101/gad.901601</pub-id>
<pub-id pub-id-type="pmid">11445544</pub-id></mixed-citation>
</ref>
<ref id="mgg31086-bib-0024">
<mixed-citation id="mgg31086-cit-0024" publication-type="journal">
<string-name>
<surname>Tsai</surname>, <given-names>E. A.</given-names>
</string-name>, <string-name>
<surname>Grochowski</surname>, <given-names>C. M.</given-names>
</string-name>, <string-name>
<surname>Falsey</surname>, <given-names>A. M.</given-names>
</string-name>, <string-name>
<surname>Rajagopalan</surname>, <given-names>R.</given-names>
</string-name>, <string-name>
<surname>Wendel</surname>, <given-names>D.</given-names>
</string-name>, <string-name>
<surname>Devoto</surname>, <given-names>M.</given-names>
</string-name>, … <string-name>
<surname>Spinner</surname>, <given-names>N. B.</given-names>
</string-name> (<year>2015</year>). <article-title>Heterozygous deletion of FOXA2 segregates with disease in a family with heterotaxy, panhypopituitarism, and biliary atresia</article-title>. <source xml:lang="en"/>Human Mutation, <volume>36</volume>(<issue>6</issue>), <fpage>631</fpage>–<lpage>637</lpage>. <pub-id pub-id-type="doi">10.1002/humu.22786</pub-id>
<pub-id pub-id-type="pmid">25765999</pub-id></mixed-citation>
</ref>
<ref id="mgg31086-bib-0025">
<mixed-citation id="mgg31086-cit-0025" publication-type="journal">
<string-name>
<surname>Vajravelu</surname>, <given-names>M. E.</given-names>
</string-name>, <string-name>
<surname>Chai</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Krock</surname>, <given-names>B.</given-names>
</string-name>, <string-name>
<surname>Baker</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Langdon</surname>, <given-names>D.</given-names>
</string-name>, <string-name>
<surname>Alter</surname>, <given-names>C.</given-names>
</string-name>, &amp; <string-name>
<surname>De Leon</surname>, <given-names>D. D.</given-names>
</string-name> (<year>2018</year>). <article-title>Congenital hyperinsulinism and hypopituitarism attributable to a mutation in FOXA2</article-title>. <source xml:lang="en"/>Journal of Clinical Endocrinology and Metabolism, <volume>103</volume>(<issue>3</issue>), <fpage>1042</fpage>–<lpage>1047</lpage>. <pub-id pub-id-type="doi">10.1210/jc.2017-02157</pub-id>
<pub-id pub-id-type="pmid">29329447</pub-id></mixed-citation>
</ref>
<ref id="mgg31086-bib-0026">
<mixed-citation id="mgg31086-cit-0026" publication-type="journal">
<string-name>
<surname>Wang</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<surname>Gauthier</surname>, <given-names>B. R.</given-names>
</string-name>, <string-name>
<surname>Hagenfeldt‐Johansson</surname>, <given-names>K. A.</given-names>
</string-name>, <string-name>
<surname>Iezzi</surname>, <given-names>M.</given-names>
</string-name>, &amp; <string-name>
<surname>Wollheim</surname>, <given-names>C. B.</given-names>
</string-name> (<year>2002</year>). <article-title>Foxa2 (HNF3beta ) controls multiple genes implicated in metabolism‐secretion coupling of glucose‐induced insulin release</article-title>. <source xml:lang="en"/>Journal of Biological Chemistry, <volume>277</volume>(<issue>20</issue>), <fpage>17564</fpage>–<lpage>17570</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M111037200</pub-id>
<pub-id pub-id-type="pmid">11875061</pub-id></mixed-citation>
</ref>
<ref id="mgg31086-bib-0027">
<mixed-citation id="mgg31086-cit-0027" publication-type="journal">
<string-name>
<surname>Weinstein</surname>, <given-names>D. C.</given-names>
</string-name>, <string-name>
<surname>Ruiz i Altaba</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Chen</surname>, <given-names>W. S.</given-names>
</string-name>, <string-name>
<surname>Hoodless</surname>, <given-names>P.</given-names>
</string-name>, <string-name>
<surname>Prezioso</surname>, <given-names>V. R.</given-names>
</string-name>, <string-name>
<surname>Jessell</surname>, <given-names>T. M.</given-names>
</string-name>, … … (<year>1994</year>). <article-title>The winged‐helix transcription factor HNF‐3 beta is required for notochord development in the mouse embryo</article-title>. <source xml:lang="en"/>Cell, <volume>78</volume>(<issue>4</issue>), <fpage>575</fpage>–<lpage>588</lpage>. <pub-id pub-id-type="doi">10.1016/0092-8674(94)90523-1</pub-id>
<pub-id pub-id-type="pmid">8069910</pub-id></mixed-citation>
</ref>
<ref id="mgg31086-bib-0028">
<mixed-citation id="mgg31086-cit-0028" publication-type="journal">
<string-name>
<surname>Williams</surname>, <given-names>P. G.</given-names>
</string-name>, <string-name>
<surname>Wetherbee</surname>, <given-names>J. J.</given-names>
</string-name>, <string-name>
<surname>Rosenfeld</surname>, <given-names>J. A.</given-names>
</string-name>, &amp; <string-name>
<surname>Hersh</surname>, <given-names>J. H.</given-names>
</string-name> (<year>2011</year>). <article-title>20p11 deletion in a female child with panhypopituitarism, cleft lip and palate, dysmorphic facial features, global developmental delay and seizure disorder</article-title>. <source xml:lang="en"/>American Journal of Medical Genetics Part A, <volume>155a</volume>(<issue>1</issue>), <fpage>186</fpage>–<lpage>191</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.33763</pub-id>
<pub-id pub-id-type="pmid">21204230</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>